期刊文献+

母血胎儿游离DNA用于无创产前诊断染色体异常疾病准确性的系统评价 被引量:4

Accuracy of maternal serum free fetal DNA for prenatal diagnosis of chromosomal abnormalities:a systematic review
下载PDF
导出
摘要 目的:评价母血胎儿游离DNA无创产前诊断染色体异常方法的准确性。方法:对Medline数据库进行文献检索,关键词为全文检索"prenatal"和"aneuploidy"和"noninvasive"或"non-invasive"和"maternal",对检索的文章用QUADAS工具筛选,对符合标准的文章进行全文分析。结果:4篇研究文章符合QUADAS所设定的标准,21-三体综合征无创产前诊断4 167例,灵敏度为100.00%,特异性为99.30%;18-三体综合征无创产前诊断共3 455例灵敏度为97.40%,特异性为99.95%。结论:母血胎儿游离DNA无创产前诊断染色体异常方法具有高精确性。 Objective:To evaluate the accuracy of maternal serum free fetal DNA used for noninvasive prenatal diagnosis of chromoso- mal abnormalities. Methods :Medline database was searched with keywords of 'prenatal' and 'aneuploidy' and 'noninvasive' or 'non-invasive' and 'maternal' by QUADAS tool,then the eligible full-texts were analyzed. Results:Four articles complied with the QUADAS standards. Noninvasive prenatal diagnosis was performed on 4 167 trisomy-21 syndrome cases,with sensitivity of 100.00% and specificity of 99.30% ;non-invasive prenatal diagnosis was performed on 3 455 trisomy-18 syndrome cases,with sensitivity of 97.40% and specificity of 99.95%. Conclusion : Maternal serum fetal free DNA used for noninvasive prenatal diagnosis of chromosomal abnormalities is of high accuracy
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2013年第10期1130-1132,共3页 Journal of Chongqing Medical University
基金 国家临床重点专科建设经费资助项目(编号:201101ckZD)
关键词 无创 产前诊断 染色体异常 noninvasive prenatal diagnosis chromosomal abnormalities
  • 相关文献

参考文献1

二级参考文献19

  • 1Nicopoullos JD, Gilling-Smith C, Almeida PA, et al. The role of sperm aneuploidy as a predictor of the success of intracytoplasmic sperm injection. Hum Reprod, 2008,23t 240-250.
  • 2Bryndorf T, Lundsteen C, Lamb A, et al. Rapid prenatal diagnosis of chromosome aneuploidies by interphase fluorescence in situ hybridization: a one-year clinical experience with high-risk and urgent fetal and postnatal samples. Aeta Obstet Gynecol Scand, 2000,79: 8-14.
  • 3Witters I, Devriendt K, Legius E, et al. Rapid prenatal diagnosis of trisomy 21 in 5049 fluid samples by fluorescence Prenat Diagn, 2002,22: 29-33. consecutive uncultured amniotie in situ hybridisation (FISH).
  • 4Driscoll DA, Gross S. Clinical practice. Prenatal screening for aneuploidy. N Engl J Med, 2009,360: 2556-2562.
  • 5Dear PH. One by one: Single molecule tools for genomics. Brief Funct Genomic Proteomic, 2003,1 : 397-416.
  • 6Boormans EM, Birnie E, Wildsehut HI, et al. Multiplex ligation-dependent probe amplification versus karyotyping in prenatal diagnosis: the M. A. K. E. study. BMC Pregnancy Childbirth, 2008,8: 18.
  • 7Chiu RW, Chan KC, Gao Y, eta|. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A, 2008,105- 20458-20463.
  • 8Fan HC, Blumenfeld YJ, Chitkara U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A, 2008,105: 16266- 16271.
  • 9Chiu RW, Akolekar R, Zheng YW, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing- large scale validity study. BMJ, 2011,342, c7401.
  • 10Weisz B, Pandya P, Chitty L, et al. Practical issues drawn from the implementation of the integrated test for Down syndrome screening into routine clinical practice. BJOG, 2007,114: 493- 497.

共引文献41

同被引文献29

  • 1肖红梅,谭跃球,李麓芸,卢光琇.应用荧光原位杂交产前诊断未培养羊水细胞非整倍体[J].中华医学遗传学杂志,2004,21(6):608-610. 被引量:13
  • 2Avent ND. Maternal plasma biomarkers for Down syndrome:pre?sentand future[J]. Drugs Today(Barc) ,2013,49(2): 145-152.
  • 3Mazloom AR,DZakula Z,Oeth P,et al. Noninvasive prenatal de?tection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma[J]. Prenat Diagn,2013,33(6) :591- 597.
  • 4Chen EZ, Chiu RW, Sun H, et al. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing[J]. PLoS One,2011 ,6(7) :e21791.
  • 5Platt LD,Janicki MB,Prosen T ,et al. Impact of noninvasive prena?tal testing in regionally dispersed medical centers in the United States[J]. AmJ Obstet Gynecol,2014,211(4):368.el-7.
  • 6Ulmer R, et al. Diagnosis of an euploidy with fluorescence in situ hybridization (FISH) ; value in pregnancies with increased risk for chro?mosome aberrations[J]. Z Geburtshilfe Neonato, 2000,204(1) : 1-7.
  • 7Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum[J]. Lancet, 1997,350(9076):485-487.
  • 8Nicolaides KH,Syngelaki A,Ashoor G,et al. Noninvasive prena?tal testing for fetal trisomies in a routinely screened first-trimester pop?ulation[J]. AmericanJournal of Obstetrics & Gynecology ,2012,207(5): 374.el-6.
  • 9Dan S, Wang W ,RenJ ,et al. Clinical application of massively par?allel sequencing -based prenatal noninvasive fetal trisomy test for tri?somies 21 and 18 in 11 105 pregnancies with mixed risk actors[J]. Pre?natal Diagnosis, 2012, 32(13) : 1225-1232.
  • 10Norton ME,Jacobsson B,Swamy GK,et al. Cell-free DNA analy?sis for noninvasive examination of trisomy[J]. The New EnglandJournal of Medicine,2015,372( 17); 1589-1597.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部